Lanin PharmaLaninPHARMA MARKET ANALYTICS

LANIN REPORTS

Chile's public pharmaceutical market, as data.

Every tender, bid and purchase order since 2020 — Cenabast and hospitals — cleaned, matched to molecules and verifiable line by line. For manufacturers evaluating Chile, business-development teams choosing a portfolio, and labs or distributors who want one molecule in depth without a subscription.

WHAT YOU CAN BUY

Three reports and a data feed.

Molecule Brief

the zoom

“How much is bought, at what price, who wins, and when does it re-tender?”

What you get

  • One molecule in depth, tender by tender — 36-month window, Cenabast and hospitals.
  • Volume tendered and awarded per year, and the awarded unit price per year.
  • Bidders per tender, with bidders and awardees named in every one.
  • Current contract timeline, its expiry, and the re-tender calendar.
  • Valid ISP registrations and their holders, plus recent entrants.
  • Raw XLSX with every bid behind the figures.
  • PDF of 4–6 pages, plus the XLSX.

Delivery · 5 business days

USD 600

per molecule · 5 for 2,700 · 10 for 4,900

Request a brief

Market Report

“What does the market for category X — or the whole public market — look like?”

What you get

  • By ATC level-1 or therapeutic area — or the full public market.
  • Market size per year and the molecule ranking within it.
  • Awarded prices and how concentrated the bidders are.
  • Contracts and the fiscal-year tender calendar.
  • New registrations over the period.

Delivery · 10 business days

USD 2,900

per category (Cenabast) · +1,500 with the hospital market · Full Cenabast and Full Public Market on request

Request a report

Portfolio Screening

the map

“Which of my products have a market in Chile?”

What you get

  • Your product list becomes one row per product, to compare and choose.
  • Market size by channel — units, CLP and USD.
  • Awarded price band, how many competitors, and who leads.
  • Entry route: a valid registration already exists, or there is none.
  • A one-page detail per product behind the comparison.
  • A snapshot at a date, not a live feed.

Delivery · 5 business days

Request a quote

priced by list size

Request a quote

Data License / Transfer

“I want the data in my own BI.”

The Cenabast dataset with a documented schema: an annual licence with quarterly refresh, or a one-time transfer. Full public market on request. Internal-use licence, no redistribution.

Request a quote

Prices in USD, ex-VAT where applicable. Every report states its data cut-off date. Internal-use licence; no redistribution.

Every report counts toward the platform.

50% of any Reports purchase is credited to your first year of Lanin Pharma Tenders when you subscribe for your Chilean operation — or your local partner’s.

HOW IT IS BUILT

  • 1.8M bids since 2020, including 1.4M losing bids — the prices that did not win.
  • Cenabast and hospital purchase orders, matched to molecule and presentation.
  • ISP registry joined to every bidder where it can be verified; blank where it cannot.
  • Every figure traceable to its public source; the data cut-off is printed on every report.

THE SAMPLE

See the format before you pay.

The free sample shows the format on one molecule: volumes, awarded prices, bidders per tender and contract expiries. It does not include bidder names or registrations — those are in the paid brief.

What the sample contains

  • Volume tendered and awarded, by year
  • Awarded unit price, by year
  • Number of bidders per tender
  • Contract timeline and expiry dates

QUESTIONS

How fresh is the data?
Updated daily from Mercado Público. Each report states its cut-off date.
Can I choose the molecules?
Yes — any molecule tendered in Chile. If it has no public-market history, we tell you before you pay.
What is the difference between a Brief and a Screening?
The Screening is the map: one row per product, to choose. The Brief is the zoom: one molecule, tender by tender, with names and the raw data.
How do I pay?
Invoice in USD, by bank transfer.
Can I share the report?
Internal use within your company. No redistribution or resale.
Do you cover private or retail?
Not in Reports. Public market only — Cenabast, hospitals and health services.

REQUEST A QUOTE

Tell us what you need.

We reply within one business day with scope, price and delivery date.

Or write directly to guillermo@laninpharma.com